Girish Aakalu
Corporate Officer/Principal bei GENOCEA BIOSCIENCES, INC.
Profil
Girish Aakalu is currently the Chief Executive Officer at Phenomic AI, Inc. since 2022 and the Chief Business Officer at Genocea Biosciences, Inc. since 2018.
Previously, he worked at Pfizer Inc. as the Executive Director, Head-Strategy & Innovation.
Dr. Aakalu completed his undergraduate degree at The Johns Hopkins University and holds graduate and doctorate degrees from the California Institute of Technology.
Aktive Positionen von Girish Aakalu
Unternehmen | Position | Beginn |
---|---|---|
GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 10.12.2018 |
Phenomic AI, Inc.
Phenomic AI, Inc. Packaged SoftwareTechnology Services Phenomic AI, Inc. develops machine-learning technology for drug discovery. It provides application of deep learning to biological imaging screens and chemo-informatics. The company was founded by Oren Kraus and Sam Cooper and is headquartered in Toronto, Canada. | Chief Executive Officer | 01.06.2022 |
Ehemalige bekannte Positionen von Girish Aakalu
Unternehmen | Position | Ende |
---|---|---|
PFIZER, INC. | Director/Board Member | - |
Ausbildung von Girish Aakalu
The Johns Hopkins University | Undergraduate Degree |
California Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
GENOCEA BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Phenomic AI, Inc.
Phenomic AI, Inc. Packaged SoftwareTechnology Services Phenomic AI, Inc. develops machine-learning technology for drug discovery. It provides application of deep learning to biological imaging screens and chemo-informatics. The company was founded by Oren Kraus and Sam Cooper and is headquartered in Toronto, Canada. | Technology Services |